The predicated demise of racemic new molecular entities is an exaggeration
Nat Rev Drug Discov
.
2012 Dec;11(12):972-3.
doi: 10.1038/nrd3657-c1.
Authors
Israel Agranat
,
Silvya R Wainschtein
,
Enav Z Zusman
PMID:
23197042
DOI:
10.1038/nrd3657-c1
No abstract available
Publication types
Letter
MeSH terms
Drug Approval*
Drug Discovery*
Stereoisomerism
United States
United States Food and Drug Administration